arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Xtant Medical Holdings, Inc.

XTNT
$0.43 ▼ -0.01 (-3.28%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
17 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Neutral
auto_awesome

Analytical Summary

Xtant Medical Holdings, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $60.0M
Dividend Yield
Revenue Growth 14.2%
Op. Margin 5.4%
ROIC 8.3%
FCF / Share $0.07
Trailing P/E 10.8x
Price / Book 1.2x
FCF Yield 16.9%
Debt / Equity 0.22
info Valuation on last close. End-of-day price, Aug 6, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$133.93M
↑ +14.2%
Net Income Profit after all expenses
$4.97M
↑ +130.2%
Operating Margin Operating profit as % of sales
5.4%
↑ +152.8% 44th
FCF / Share Free cash flow per share
$0.07
↑ +160.8%
Long-Term Debt Long-term obligations
$11.03M
↓ -50.0%

Health Breakdown

Profitability
47
Returns
67
Financial Health
65
Cash Quality
86

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 66 quarters